Contract J903
Amerisourcebergen Drug Corp · Department Of Defense · October 27, 1997
Amerisourcebergen Drug Corp was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on October 27, 1997 for $18.70 million of work in medicinal and botanical manufacturing. Performance is in Chesterbrook, PA. This is a task or delivery order issued under parent IDIQ SPE2DX15D1907. The contract has been modified 222 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on November 23, 2017.
Contract details
- PIID
- J903
- Parent IDIQ
- SPE2DX15D1907
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325411 · Medicinal And Botanical Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Chesterbrook, PA
- First action
- October 27, 1997
- Latest action
- November 23, 2017
Description
4539153660!EUROPE
Modification timeline
-
November 23, 2017Mod 1$-0
-
November 21, 2017Mod 2GBS - AREA III (SOUTHEAST)$-60
-
September 5, 2017Base award4539215281!ALPHALYSE 360 F/ABX MICROS$221
-
August 29, 2017Base award$25
-
August 1, 2017Base award4538818013!INFLUENZA AB TEST KIT BINAXNOW 22S$249
-
June 21, 2017Base award4538418432!ST PLUS 692&PADDED CASE W/O WALLHOLDER$351
-
June 19, 2017Base award4538392976!ARTHROSCOPE, 30DEG, 2.4 X 72MM$10.0K
-
June 17, 2017Base award4538359843!TRBO REGION 7/8$742
-
May 16, 2017Base award4538045124!SALIVA EJEC FLEXO BLU BG100$11
-
May 10, 2017Base award4537987379!TRBO REGION 7/8$4
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $232 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $13.1K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $1.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $220.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $135 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $39.8K |
Top contractors in NAICS 325411
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 372,977 | $24.02B |
| 2 | Amerisourcebergen Drug Corp | 1,414,856 | $18.32B |
| 3 | Glaxosmithkline, Llc | 44 | $5.42B |
| 4 | Merck Sharp & Dohme Llc | 3 | $1.50B |
| 5 | Novartis Vaccines And Diagnostics, Inc. | 132 | $1.07B |
| 6 | Sanofi Vaccines Us Inc. | 57 | $650.53M |
| 7 | Cardinal Health, Inc. | 42,916 | $603.29M |
| 8 | Dms Pharmaceutical Group Inc | 113,930 | $547.06M |
| 9 | Cardinal Health 100, Inc | 7,655 | $486.24M |
| 10 | Glaxosmithkline Holdings (Americas) Inc. | 72 | $280.01M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract J903?
Contract J903 is a federal contract awarded to Amerisourcebergen Drug Corp by Department Of Defense on October 27, 1997 for $18.70 million of work classified under MEDICINAL AND BOTANICAL MANUFACTURING. It has been modified 222 times since the base award.
Who won contract J903?
Amerisourcebergen Drug Corp won contract J903 from Department Of Defense.
How much is contract J903 worth?
Contract J903 has obligated $18.70 million to date.